Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
abortion
Biotech
Biotech leaders urge FDA to not restrict abortion pill access
The letter notes that there are "over a hundred peer-reviewed studies" demonstrating mifepristone's safety and efficacy.
Darren Incorvaia
Jul 2, 2025 2:14pm
Biopharma relieved as High Court upholds abortion pill—for now
Apr 26, 2023 9:55am
Biopharmas take abortion pill fight to the courts with brief
Apr 12, 2023 11:20am
Biotech leaders push back after judge blocks abortion pill
Apr 10, 2023 9:30am
Biotech's women leaders decry abortion bans
Jul 5, 2022 10:52am
Genetic test results harder to handle under new abortion rules
Jun 27, 2022 9:07am
